About the Gastrointestinal Stromal Tumor Session
Gastrointestinal stromal tumors (GISTs), though rare, stand as a focal point in cancer research, owing to their unique molecular makeup. These tumors typically arise in the gastrointestinal tract, primarily the stomach or small intestine. Their development is often linked to mutations in genes like KIT or PDGFRA, which play pivotal roles in cell growth regulation. Breakthroughs in targeted therapies, notably with drugs like imatinib, have reshaped GIST treatment by specifically targeting these mutated proteins. Yet, challenges persist, notably in drug resistance. Current investigations delve into innovative treatment avenues and delve into the intricacies of the tumor microenvironment for enhanced diagnostic and therapeutic strategies. By deciphering the intricate biology of GISTs, researchers strive to pave the way for more tailored and effective treatment modalities for this clinically significant yet relatively uncommon cancer.
Topics Covered in Gastrointestinal Stromal Tumor
KIT & PDGFRA Mutations
Wild-Type Tumors
Risk Stratification
Surgical Resection
Tyrosine Kinase Inhibitors
Secondary Resistance
Related Scientific Sessions at CIOC 2027
Why Attend the Gastrointestinal Stromal Tumor Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Gastrointestinal Stromal Tumor work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Gastrointestinal Stromal Tumor research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Gastrointestinal Stromal Tumor track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Gastrointestinal Stromal Tumor Conference 2027 — FAQs
What is the Gastrointestinal Stromal Tumor track at CIOC 2027?
The Gastrointestinal Stromal Tumor track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Gastrointestinal Stromal Tumor. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Gastrointestinal Stromal Tumor sessions?
Cancer researchers and clinicians, educators and students with an interest in Gastrointestinal Stromal Tumor are all welcome — whether presenting or attending.
Can I present my research in the Gastrointestinal Stromal Tumor track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Gastrointestinal Stromal Tumor sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Gastrointestinal Stromal Tumor track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.